Aisha Khan
Primary Care · Schaumburg, ILNPI 1902588213
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.
Across 130 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$622
- AstraZeneca$330
- Novo Nordisk$320
- Dexcom, Inc.$319
- Boehringer Ingelheim$168
- AbbVie$116
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 26 | $622 |
| AstraZeneca | 18 | $330 |
| Novo Nordisk | 12 | $320 |
| Dexcom, Inc. | 12 | $319 |
| Boehringer Ingelheim | 7 | $168 |
| AbbVie | 5 | $116 |
| Medtronic | 1 | $101 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $89 |
| Sequel Med Tech, LLC | 1 | $86 |
| Corcept Therapeutics | 3 | $85 |
| GSK | 3 | $72 |
| Inspire Medical Systems, Inc. | 3 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Amgen | 3 | $57 |
| Recordati_rare_diseases_inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Exact Sciences | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Johnson & Johnson | 2 | $42 |
| Pfizer | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Seqirus USA Inc | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Cipher Pharmaceuticals US LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| BETA Bionics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$125
- MINIMED 780G$101
How this compares
$3,086 in reported general payments places this provider in the 85th percentile of 150 primary care providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $11,198 |
| Gabapentin | 29 | $337 |
| Enalapril Maleate | 11 | $252 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $196 |
| Atorvastatin Calcium | 21 | $190 |
| Fluticasone Propionate | 17 | $176 |
| Alendronate Sodium | 18 | $163 |
| Methylprednisolone | 28 | $120 |
| Azithromycin | 30 | $107 |
| Levothyroxine Sodium | 12 | $87 |
| Lisinopril | 16 | $84 |
| Trazodone Hcl | 13 | $83 |
| Amoxicillin | 17 | $71 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $51 |
| Cyclobenzaprine Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $320 | $11,19812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 150 primary care providers in Illinois.
Other primary care in Schaumburg
- Nicole LorangElk Grove Village$19K
- Allison LindstromChicago$15K
- Rachel ProkopfOak Park$13K
- Dawn ConwayChicago$11K
- Anne MaynardGlen Ellyn$9K
- Megan McLuckieHoffman Estates$9K
- Megan NiemiecNew Lenox$7K
- Ashley CarterChicago$7K
- Blake WoodsMetropolis$6K
- Jennifer VazquezChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.